The Food and Drug Administration's potential breakthrough drug for diabetes — which has the capacity to delay the onset of Type 1 diabetes — could be ready for high-risk patients before January.
Facebook officials said Wednesday that the social media platform has no plans to reinstate the account of former President Donald Trump, despite announcing his bid earlier this week for a second term in the White House in 2024.